Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Standardization of platelet releasate products for clinical applications in cell therapy: a mathematical approach

Fig. 3

Concentrations of generated thrombin when low recombinant tissue factor (LTF) or high recombinant tissue factor (HTF) amounts were added to samples of platelet rich plasma (PRP) from platelet apheresis product (as control) or to samples of SRGF pool batches comprising n = 16 single donor specimens. Thrombin availability in SRGF was demonstrated to be undetectable

Back to article page